Scarborough Advisors’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52M Buy
1,202,547
+664,364
+123% +$28.2M 5.97% 3
2026
Q1
$21M Buy
538,183
+2,243
+0.4% +$91K 2.3% 13
2025
Q4
$21.9M Buy
535,940
+8,369
+2% +$341K 3.7% 9
2025
Q3
$21.3M Sell
527,571
-40,380
-7% -$1.56M 3.76% 9
2025
Q2
$20.9M Buy
567,951
+132,201
+30% +$4.48M 4.14% 8
2025
Q1
$14.5M Buy
435,750
+13,303
+3% +$463K 2.06% 12
2024
Q4
$14.6M Buy
+422,447
New +$14.8M 2.07% 14

Other funds holding RECS

Scarborough Advisors's RECS Position: Q2 2026 in Review

Scarborough Advisors increased its Columbia Research Enhanced Core ETF (RECS) stake by 123% in Q2 2026, buying an estimated $28.2M and bringing the position to 1,202,547 shares worth $52M. The position accounts for 5.97% of the portfolio, ranked #3.

Scarborough Advisors first reported a position in RECS in Q4 2024 and has held it in 7 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Scarborough Advisors held 1,202,547 shares of Columbia Research Enhanced Core ETF worth $52M as of Q2 2026.
  • Scarborough Advisors bought 664,364 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $28.2M.
  • Columbia Research Enhanced Core ETF made up 5.97% of Scarborough Advisors's portfolio in Q2 2026, its #3 holding.
  • Scarborough Advisors first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and has held it in 7 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.